Attovia Therapeutics 在IPO规模扩大至2.89亿美元后,有望在纳斯达克上市首日大涨

路透中文
Aug 05
BUZZ-<a href="https://laohu8.com/S/ATTO">Attovia Therapeutics</a> 在IPO规模扩大至2.89亿美元后,有望在纳斯达克上市首日大涨

8月5日 - ** 阿托维亚治疗公司(Attovia Therapeutics,股票代码: ATTO.O)在将美国首次公开募股(IPO)规模扩大至2.89亿美元后,其纳斯达克首日上市开盘价有望远高于发行价

** 该股最新显示开盘价为每股24美元,而IPO发行价为17美元

** 总部位于加利福尼亚州圣卡洛斯的 ATTO((link))于周二晚间以每股17美元的价格售出1700万股 (link),此次IPO规模已扩大 (link)

** ATTO公司致力于研发免疫介导性疾病的治疗方案,最初计划发行约1250万股,定价区间为每股15至17美元

** 其主要研发项目包括ATTO-1310,该药物正在开发用于治疗慢性瘙痒性疾病

** 摩根士丹利、Leerink Partners、花旗集团加拿大皇家银行资本市场担任此次发行的联合簿记管理人

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10